Lenalidomide with Dexamethasone to Multiple Myeloma Patients Relapsing from Bortezomib-Based Inducti...
Lenalidomide with Dexamethasone to Multiple Myeloma Patients Relapsing from Bortezomib-Based Induction Therapies: a Prospective, Observational Study
About this item
Full title
Author / Creator
Publisher
India: Wolters Kluwer - Medknow
Journal title
Language
English
Formats
Publication information
Publisher
India: Wolters Kluwer - Medknow
Subjects
More information
Scope and Contents
Contents
Lenalidomide with dexamethasone (Len/Dex) is considered to be an effective and well-tolerated regimen to treat multiple myeloma (MM) patients relapsing after bortezomib induction therapy. With the increase in novel agents targeting refractory and relapsed MM, the identification of clinical or laboratory variables that can predict the appropriate ca...
Alternative Titles
Full title
Lenalidomide with Dexamethasone to Multiple Myeloma Patients Relapsing from Bortezomib-Based Induction Therapies: a Prospective, Observational Study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_490dc38ac895465c87749439caed4c69
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_490dc38ac895465c87749439caed4c69
Other Identifiers
ISSN
0304-4920
E-ISSN
2666-0059
DOI
10.4103/CJP.CJP_68_20
